天津市依依卫生用品股份有限公司董事会 关于本次交易前 12 个月内购买、出售资产情况的说明 1 （本页无正文，为《天津市依依卫生用品股份有限公司董事会关于本次交易前 12 个月内购买、出售资产情况的说明》之盖章页） 天津市依依卫生用品股份有限公司董事会 2025年10月24日 2 天津市依依卫生用品股份有限公司（以下简称"公司"）拟以发行股份及支 付现金的方式购买杭州高爷家有好多猫宠物食品有限责任公司（以下简称"标的 资产"）100%的股权，并募集配套资金（以下简称"本次交易"）。 根据《上市公司重大资产重组管理办法》第十四条的有关规定："上市公司 在十二个月内连续对同一或者相关资产进行购买、出售的，以其累计数分别计算 相应数额。已按照本办法的规定编制并披露重大资产重组报告书的资产交易行为， 无须纳入累计计算的范围。中国证监会对本办法第十三条第一款规定的重大资产 重组的累计期限和范围另有规定的，从其规定。交易标的资产属于同一交易方所 有或者控制，或者属于相同或者相近的业务范围，或者中国证监会认定的其他情 形下，可以认定为同一或者相关资产"。本次交易前十二个月内，公司不存在需 纳入本次重组相关指标累计计算范围的 ...

天津市依依卫生用品股份有限公司（以下简称"公司"或"上市公司"）正 在筹划以发行股份及支付现金的方式取得杭州高爷家有好多猫宠物食品有限责 任公司全部股权并募集配套资金（以下简称"本次交易"），根据深圳证券交易所 的相关规定，经公司申请，公司股票（证券简称：依依股份，证券代码：001206） 自 2025 年 10 月 14 日（星期二）开市时起开始停牌，具体内容详见公司于 2025 年 10 月 14 日在指定信息披露媒体及巨潮资讯网（http://www.cninfo.com.cn）披 露的《关于筹划发行股份及支付现金购买资产并募集配套资金事项的停牌公告》 （公告编号：2025-062）。停牌期间，公司按照相关规定于 2025 年 10 月 21 日披 露了《关于筹划发行股份及支付现金购买资产并募集配套资金事项的停牌进展公 告》（公告编号：2025-064）。 证券代码：001206 证券简称：依依股份 公告编号：2025-069 天津市依依卫生用品股份有限公司 关于披露发行股份及支付现金购买资产并募集配套资金 预案的一般风险提示暨公司股票复牌的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整 ...

特此说明。 天津市依依卫生用品股份有限公司 天津市依依卫生用品股份有限公司董事会关于本次交易信息发布前 公司股票价格波动情况的说明 天津市依依卫生用品股份有限公司（以下简称"公司"）拟通过发行股份及 支付现金方式向彭瀚、闻光凯等 19 名交易对方购买杭州高爷家有好多猫宠物食 品有限责任公司 100.00%股权并募集配套资金（以下简称"本次交易"）。 因筹划本次交易事项，经向深圳证券交易所申请，公司股票自 2025 年 10 月 14 日开市起停牌，在停牌前 20 个交易日内的累计涨跌幅以及相同时间区间内 深证成指（399001.SZ）及万得宠物经济指数（8841147.WI）的累计涨跌幅情况 如下表所示： | 项目 | 停牌前第 | 21 | 个交易日 | | 停牌前第 | 1 | 个交易日 | 涨跌幅 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | （2025 | 年 月 9 | 5 | 日） | 年 （2025 | 月 10 | 日） 13 | | | 公司股票收盘价（元/股） | | 28.30 | | | | 34.85 | ...

证券代码：001206 证券简称：依依股份 公告编号：2025-068 天津市依依卫生用品股份有限公司 关于暂不召开股东会审议本次交易相关事项的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 天津市依依卫生用品股份有限公司（以下简称"公司"）正在筹划以发行股 份及支付现金的方式取得杭州高爷家有好多猫宠物食品有限责任公司全部股权 并募集配套资金（以下简称"本次交易"）。 公司于 2025 年 10 月 24 日召开第四届董事会第三次会议，审议通过了《关 于公司发行股份及支付现金购买资产并募集配套资金方案的议案》《关于<天津市 依依卫生用品股份有限公司发行股份及支付现金购买资产并募集配套资金预案> 及其摘要的议案》等与本次交易相关的议案，具体内容详见公司于同日在指定信 息披露媒体及巨潮资讯网（http://www.cninfo.com.cn）披露的相关公告及文件。 鉴于本次交易的相关审计、评估工作尚未完成，公司决定暂不召开股东会审 议本次交易相关议案。在相关审计、评估工作完成后，公司董事会将再次召开会 议审议本次交易相关事项，并依法定程序召集股东会审议本次交 ...

证券代码：001206 证券简称：依依股份 公告编号：2025-065 天津市依依卫生用品股份有限公司 第四届董事会第三次会议决议公告 3.回避表决情况： 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 天津市依依卫生用品股份有限公司（以下简称"公司"）第四届董事会第三 次会议通知已于 2025 年 10 月 20 日通过电话、邮件方式送达。会议于 2025 年 10 月 24 日以现场表决的方式在公司会议室召开。本次会议应出席董事 14 名， 实际出席董事 14 名。会议由董事长高福忠先生主持，公司全部高级管理人员列 席了会议。本次会议的召开和表决程序符合《中华人民共和国公司法》（以下简 称"《公司法》"）等法律、法规、规范性文件和《天津市依依卫生用品股份有 限公司章程》（以下简称"《公司章程》"）的有关规定，会议合法、有效。 二、董事会会议审议情况 (一) 审议通过《关于公司<2025 年第三季度报告>的议案》 1.议案内容： 公司《2025 年第三季度报告》的编制程序符合法律、法规和《公司章程》 的相关规定，其内容和格式符合中国证 ...

证券代码：001206 证券简称：依依股份 公告编号：2025-066 天津市依依卫生用品股份有限公司 天津市依依卫生用品股份有限公司 2025 年第三季度报告 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 √否 1 天津市依依卫生用品股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入（元） | 417,715,413.59 | -1 ...

Group 1: OSL Group - OSL Group is currently the only publicly listed licensed virtual asset exchange in Asia, benefiting from a rare licensing barrier and diversified product expansion, which provides a first-mover advantage [1][3] - The company is expected to achieve profitability for the first time in 2024 since its strategic shift to the digital asset industry in 2018, with net profits projected to be -0.66/-0.12/0.20 million HKD for 2025-2027 [2][24] - OSL has obtained dual licenses from the Hong Kong Securities and Futures Commission (SFC) and Anti-Money Laundering Ordinance (AMLO), ensuring compliance and regulatory framework for its operations [3][25] - The company is accelerating global expansion through acquisitions in Japan and Europe, which is expected to drive significant revenue growth [3][25] - A strategic investment of up to 30 million USD in the PayFi ecosystem is planned to enhance payment services, which will be a key focus area for the company in the coming years [4][26] Group 2: Chengde Lululemon - Chengde Lululemon reported a significant revenue recovery in Q3, with a year-on-year growth of 8.91%, although the increase in sales expenses offset the gross margin expansion [5][6] - The company is focusing on the launch of new products, particularly the Lululemon plant-based health water series, which is expected to enhance brand competitiveness and capture market demand [7] - The market for traditional health water is projected to grow significantly, with an expected market size of 30 billion RMB in 2024, indicating a favorable environment for the company's new product line [7] Group 3: GCL Technology - GCL Technology's photovoltaic materials business turned profitable in Q3 2025, with an estimated profit of approximately 9.6 billion RMB, marking a significant recovery [8][34] - The company is expected to achieve net profits of -13.81/13.17/20.55 billion RMB for 2025-2027, reflecting a positive outlook for future profitability [8][34] - The company is benefiting from a reduction in competition and a focus on core business areas, which is expected to enhance its operational efficiency [8][34]

Core Insights - On October 23, 2023, brokerage firms provided target prices for listed companies, with significant increases noted for companies in the pet feed and communication equipment sectors, specifically Guibao Pet, StarNet RuiJie, and Weisheng Information, with target price increases of 61.09%, 50.73%, and 43.78% respectively [1][2]. Target Price Increases - Guibao Pet (301498) received a target price of 118.00 yuan, reflecting a target price increase of 61.09% from the latest closing price [2]. - StarNet RuiJie (002396) has a target price of 39.16 yuan, with a target price increase of 50.73% [2]. - Weisheng Information (688100) has a target price of 51.00 yuan, showing a target price increase of 43.78% [2]. - Other notable companies include China Unicom (600050) with a target price increase of 36.22% and Wens Foodstuff Group (300498) with an increase of 33.28% [2]. Brokerage Recommendations - A total of 59 listed companies received brokerage recommendations on October 23, with Tonghuashun (300033) receiving the highest number of recommendations at 5, followed by Guibao Pet with 4, and Meihua Biological (600873) with 3 [3][4]. - The sectors represented include software development, feed, and chemical products [4]. Rating Adjustments - On October 23, only one company, Huayou Cobalt (603799), had its rating upgraded from "Hold" to "Buy" by Huayuan Securities [5]. - This indicates a positive outlook for the energy metals sector [5]. First-Time Coverage - Nine companies received first-time coverage from brokerages on October 23, with notable mentions including Innovation New Materials (600361) rated "Buy" by Huayuan Securities, and YunTu Holdings (002539) and Meihua Biological (600873) both rated "Buy" by Global Fortune Financial [6]. - Other companies receiving first-time ratings include Babi Food (605338) and Shengquan Group (108850) [6].

Core Viewpoint - Yiyi Co., Ltd. is actively expanding its presence in the pet market through strategic acquisitions and investments, aiming to become a comprehensive leader in the pet industry by integrating products, food, and medical services [2][5]. Group 1: Recent Actions - On October 13, Yiyi Co. announced the acquisition of Hangzhou Gaoye Family Pet Food Co., Ltd. [2] - On October 16, Yiyi Co. revealed a joint investment with Beijing Fangyuan Jinding Investment Management Co., Ltd. in a venture capital partnership with a total planned scale of 156.54 million RMB, where Yiyi Co. will contribute 70.20 million RMB, accounting for 44.84% of the partnership [2]. Group 2: Business Overview - Yiyi Co. is a leading enterprise in the disposable pet hygiene products sector, primarily producing pet pads and pet diapers, and has long provided OEM services for various international pet brands [4]. - As of the first half of 2025, disposable pet hygiene products accounted for 93.91% of Yiyi Co.'s revenue, with 93.47% of its income derived from overseas markets [4]. Group 3: Investment Targets - The investment target, Ruipai Pet Hospital, operates a large chain of pet hospitals with nearly 600 stores across 27 provinces and over 70 cities in China [4]. - Ruipai Pet Hospital has attracted investments from several major domestic and international investors and is rumored to be planning an IPO in Hong Kong [4]. Group 4: Strategic Implications - The successful completion of the acquisition of Gaoye Family and the investment in Ruipai will position Yiyi Co. as a leader in the "products + food + medical" segments of the domestic pet industry, reducing its reliance on overseas markets and OEM products [5]. - As of October 13, Yiyi Co.'s stock has increased by 118.91% this year, indicating strong market performance [5].

Core Insights - The recent actions of Yiyi Co., a leading company in the pet hygiene products sector, indicate its ambition to expand within the pet market [3] - Yiyi Co. has announced the acquisition of Hangzhou Gaoye Family Pet Food Co. and a joint investment in a venture capital fund targeting Ruipai Pet Hospital Management Co. [1][3] Group 1: Company Actions - Yiyi Co. announced the acquisition of Hangzhou Gaoye Family Pet Food Co. on October 13, followed by a joint investment with Beijing Fangyuan Jinding Investment Management Co. on October 16 [1] - The total scale of the venture capital fund is set at 156.54 million RMB, with Yiyi Co. contributing 70.20 million RMB, representing a 44.84% stake [1] Group 2: Market Position and Strategy - Yiyi Co. is a leader in the disposable pet hygiene products market, with 93.91% of its revenue coming from these products as of the first half of 2025 [1] - The company generates 93.47% of its revenue from international markets, indicating a strong reliance on overseas sales [1] Group 3: Investment Targets - Ruipai Pet Hospital operates nearly 600 stores across 27 provinces and over 70 cities in China, positioning it as a significant player in the pet healthcare sector [1] - Ruipai has attracted investments from various domestic and international investors and is rumored to be planning an IPO in Hong Kong [1] Group 4: Future Outlook - If the acquisition of Gaoye Family and the investment in Ruipai are successful, Yiyi Co. aims to become a comprehensive leader in the domestic pet industry, covering products, food, and medical services [3] - Yiyi Co. is currently suspended from trading, with plans to resume by October 28, 2025, and has seen a cumulative stock increase of 118.91% this year as of October 13 [3]